Patent · US Expired

Isolated, large latent complexes of TGF-.beta.2 and TGF-.beta.3, and new binding protein for latent form TGF-.beta.1, TGF-.beta.2 and TGF-.beta.3 LTBP-2

US5280109A · kind A · utility

33Cited by
0References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 27, 1992
Grant dateJan 18, 1994
Priority date
Expiry dateJan 27, 2012

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K14/495
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention relates to large latent complexes of TGF-.beta.2 and TGF-.beta.3, and methods for Isolating these. The complex consists of a dimerized form of TGF-.beta.2 or TGF-.beta.3, the appropriate latency associated peptide, and the latent TGF-.beta.1 binding protein, referred to as LTBP. Also described is a protein which binds to all of TGF-.beta.1, TGF-.beta.2 and TGF-.beta.3, but is immunologically distinct from LTBP, referred to as LTBP-2.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.